Shufro Rose & CO LLC Novartis Ag Transaction History

Shufro Rose & CO LLC

$1.22 Billion
Q2 2024

A detailed history of Shufro Rose & CO LLC transactions in Novartis Ag stock. As of the latest transaction made, Shufro Rose & CO LLC holds 4,000 shares of NVS stock, worth $442,240. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,000

Previous 4,000 -0.0%

Holding current value

$442,240

Previous $386,000 10.1%

% of portfolio

0.03%

Previous 0.03%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	SELL	$80.03 - $92.81 $3,201 - $3,712	-40 Reduced 0.99%	4,000 $368,000
Q4 2022 Jan 25, 2023	SELL	$75.55 - $92.52 $3,022 - $3,700	-40 Reduced 0.98%	4,040 $0
Q3 2022 Oct 24, 2022	BUY	$74.61 - $87.26 $2,984 - $3,490	40 Added 0.99%	4,080 $310,000
Q2 2022 Jul 22, 2022	SELL	$80.52 - $93.75 $16,104 - $18,750	-200 Reduced 4.72%	4,040 $342,000
Q3 2021 Nov 05, 2021	SELL	$81.78 - $95.14 $32,712 - $38,056	-400 Reduced 8.62%	4,240 $347,000
Q1 2021 Apr 28, 2021	SELL	$83.5 - $98.47 $44,088 - $51,992	-528 Reduced 10.22%	4,640 $397,000
Q4 2020 Feb 03, 2021	BUY	$78.07 - $94.43 $1,014 - $1,227	13 Added 0.25%	5,168 $488,000
Q3 2020 Oct 27, 2020	BUY	$82.14 - $91.0 $16,428 - $18,200	200 Added 4.04%	5,155 $448,000
Q2 2019 Jul 24, 2019	SELL	$75.4 - $92.8 $905,327 - $1.11 Million	-12,007 Reduced 70.79%	4,955 $452,000
Q3 2018 Oct 26, 2018	BUY	$66.94 - $77.43 $21,755 - $25,164	325 Added 1.95%	16,962 $1.46 Million
Q2 2018 Jul 27, 2018	SELL	$64.91 - $73.36 $12,008 - $13,571	-185 Reduced 1.1%	16,637 $1.26 Million
Q1 2018 May 04, 2018	SELL	$70.39 - $84.15 $28,156 - $33,660	-400 Reduced 2.32%	16,822 $1.36 Million
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $1.28 Million - $1.33 Million	17,222	17,222 $1.48 Million

Others Institutions Holding NVS

# of Institutions

1,434

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.55M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $238B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shufro Rose & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shufro Rose & CO LLC with notifications on news.

Account

Shufro Rose & CO LLC Novartis Ag Transaction History